Fulgent Genetics Inc (FLGT)
17.87
+0.92
(+5.43%)
USD |
NASDAQ |
Nov 22, 16:00
17.86
-0.01
(-0.06%)
Pre-Market: 08:02
Fulgent Genetics Enterprise Value: 332.88M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 332.88M |
| November 21, 2024 | 304.74M |
| November 20, 2024 | 314.83M |
| November 19, 2024 | 306.26M |
| November 18, 2024 | 297.39M |
| November 15, 2024 | 315.75M |
| November 14, 2024 | 330.43M |
| November 13, 2024 | 349.70M |
| November 12, 2024 | 372.33M |
| November 11, 2024 | 399.25M |
| November 08, 2024 | 380.59M |
| November 07, 2024 | 459.81M |
| November 06, 2024 | 480.00M |
| November 05, 2024 | 460.12M |
| November 04, 2024 | 445.74M |
| November 01, 2024 | 446.19M |
| October 31, 2024 | 441.31M |
| October 30, 2024 | 405.27M |
| October 29, 2024 | 397.95M |
| October 28, 2024 | 394.59M |
| October 25, 2024 | 379.32M |
| October 24, 2024 | 371.07M |
| October 23, 2024 | 371.99M |
| October 22, 2024 | 384.81M |
| October 21, 2024 | 376.57M |
| Date | Value |
|---|---|
| October 18, 2024 | 389.70M |
| October 17, 2024 | 386.65M |
| October 16, 2024 | 400.08M |
| October 15, 2024 | 404.97M |
| October 14, 2024 | 407.72M |
| October 11, 2024 | 392.14M |
| October 10, 2024 | 396.72M |
| October 09, 2024 | 393.36M |
| October 08, 2024 | 413.21M |
| October 07, 2024 | 411.38M |
| October 04, 2024 | 424.21M |
| October 03, 2024 | 413.82M |
| October 02, 2024 | 431.54M |
| October 01, 2024 | 429.70M |
| September 30, 2024 | 449.86M |
| September 27, 2024 | 328.58M |
| September 26, 2024 | 321.00M |
| September 25, 2024 | 321.30M |
| September 24, 2024 | 336.15M |
| September 23, 2024 | 344.33M |
| September 20, 2024 | 353.42M |
| September 19, 2024 | 380.99M |
| September 18, 2024 | 381.60M |
| September 17, 2024 | 376.75M |
| September 16, 2024 | 357.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
117.29M
Minimum
Mar 16 2020
4.896B
Maximum
Feb 09 2021
931.76M
Average
567.70M
Median
Oct 13 2022
Enterprise Value Benchmarks
| Delcath Systems Inc | 300.07M |
| Star Equity Holdings Inc | 33.44M |
| Exact Sciences Corp | 11.34B |
| CytoSorbents Corp | 58.43M |
| Progyny Inc | 1.079B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.65M |
| Revenue (Quarterly) | 71.74M |
| Total Expenses (Quarterly) | 88.82M |
| EPS Diluted (Quarterly) | -0.48 |
| Gross Profit Margin (Quarterly) | 37.32% |
| Profit Margin (Quarterly) | -20.42% |
| Earnings Yield | -30.89% |
| Normalized Earnings Yield | -8.515 |